"Avera Research Institute, led by Amy Elliott, PhD, seeks to improve child health and development through research."

During the past decade, Avera Research Institute conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 5 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Avera Research Institute" #1 sponsor was "Avera McKennan Hospital & University Health Center" with 12 trials, followed by "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 3 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored, "Celgene" with 2 trials sponsored and "IDeA States Pediatric Clinical Trials Network" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Avera Research Institute" #1 collaborator was "Pfizer" with 3 trials as a collaborator, "National Institutes of Health (NIH)" with 2 trials as a collaborator, "University of Montana" with 2 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Avera Research Institute" are "Alzheimer's Disease" (4 trials), "Multiple Myeloma" (4 trials), "Obesity" (3 trials), "Breast Cancer" (2 trials) and "COVID-19" (2 trials). Many other conditions were trialed in "Avera Research Institute" in a lesser frequency.

Most popular intervention types in "Avera Research Institute" are "Drug" (17 trials), "Dietary Supplement" (6 trials), "Other" (4 trials) and "Behavioral" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "IHBG-10" (3 trials), "Bapineuzumab 0.5 mg/kg" (2 trials), "Bapineuzumab 1.0 m/kg" (2 trials) and "Bortezomib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Avera Research Institute" are 32 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Avera Research Institute". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Avera Research Institute, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Avera Research Institute, 2 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".